Th increasing demand for biologics has led to an increasing need for production capacity, which is characterized by high quality standards. Although, it is a challenging field, outsourcing has emerged as a promising segment, especially for drug fill finish manufacturing and aseptic fill finish operations. Despite being one of the crucial steps of all the